ACE2 and COVID-19: Some studies pointed out that the participation of anti-ACE2 in the pro-inflammatory response during COVID-19 is linked to its inhibitory effect on the enzymatic activity of ACE2, leading to an increase in angiotensin II levels that promote inflammation [17].